Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab
Lorenzo Bertani, Brigida Barberio, Marco Fornili, Luca Antonioli, Federico Zanzi, Cesare Casadei, Laura Benvenuti, Sonia Facchin, Vanessa D’Antongiovanni, Greta Lorenzon, Linda Ceccarelli, Laura Baglietto, Nicola de Bortoli, Massimo Bellini, Francesco Costa, Edoardo Savarino, Matteo Fornai
Topics & Concepts
MedicineOncostatin MVedolizumabCalprotectinInternal medicineFaecal calprotectinInfliximabGastroenterologyBiomarkerCohortAdalimumabTumor necrosis factor alphaUlcerative colitisInflammatory bowel diseaseCytokineInterleukin 6DiseaseChemistryBiochemistryCytokine Signaling Pathways and InteractionsHeat shock proteins researchCell death mechanisms and regulation